Novo CEO pressed by Senate to chop prices of being overweight, diabetic issues medications CEO Lars Fruergaard Jørgensen informed lawmakers the organization would think about new talks with insurers in regards to the checklist charges of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. https://labelthefigurewiththeitem49493.free-blogz.com/77977182/the-smart-trick-of-healthcare-news-that-nobody-is-discussing